Li Z-D, Luo J, Jia L-H, Wang X-Y, Xun Z-K, Liu M
1 Department of Pharmacy, Electric Power Teaching Hospital, Capital Medical University, Beijing, China.
2 Department of Pharmacy, Clinical School of Air Force, Anhui Medical University, Hefei, China.
Hum Exp Toxicol. 2019 Feb;38(2):193-200. doi: 10.1177/0960327118783543. Epub 2018 Jul 17.
The receptor megalin plays an important role in the accumulation of polymyxin B (PMB) in renal cells in vitro. This study aimed to examine the effects of cytochrome c (cyto c), a typical megalin ligand, on renal accumulation and nephrotoxicity of PMB in vivo. Thirty Sprague-Dawley rats were randomly divided into the vehicle control group, PMB group, PMB + cyto c 50, 100, or 200 mg/kg group, respectively, and were treated with intravenous cyto c 30 min before the administration of PMB 4.0 mg/kg once a day for consecutive 5 days. On the 4th day after administration, 24 h urine was collected to determine N-acetyl-β-D-glucosaminidase excretion. Six hours after the last injection on the 5th day, kidneys were harvested to assay PMB concentration and observe pathological alterations, and blood samples were collected to assay serum creatinine (SCr), blood urea nitrogen (BUN), and blood β-microglobulin (β-MG) levels. Cyto c 50, 100, and 200 mg/kg decreased the accumulation of PMB in the kidney by 18.5%, 39.1% ( p < 0.01), and 36.8% ( p < 0.01), respectively, and reduced 24 h N-acetyl-β-D- glucosaminidase excretion by 22.5% ( p < 0.05), 40.4% ( p < 0.01), and 40.4% ( p < 0.01), respectively. Kidney pathological damage induced by PMB was markedly reduced by cyto c 100 mg/kg and 200 mg/kg. However, there were no significant differences in SCr, BUN, and blood β-MG levels among the groups. These results indicated that cyto c may inhibit the renal accumulation and nephrotoxicity of PMB in a rat model, further proving the role of megalin in the accumulation of PMB.
巨膜蛋白受体在体外肾细胞中多黏菌素B(PMB)的蓄积过程中发挥重要作用。本研究旨在探讨典型的巨膜蛋白配体细胞色素c(cyto c)对PMB在体内肾蓄积及肾毒性的影响。将30只Sprague-Dawley大鼠随机分为溶剂对照组、PMB组、PMB + cyto c 50、100或200 mg/kg组,在每天一次给予4.0 mg/kg PMB前30分钟静脉注射cyto c,连续5天。给药后第4天,收集24小时尿液以测定N-乙酰-β-D-氨基葡萄糖苷酶排泄量。在第5天最后一次注射后6小时,摘取肾脏以测定PMB浓度并观察病理改变,同时采集血样以测定血清肌酐(SCr)、血尿素氮(BUN)和血β-微球蛋白(β-MG)水平。cyto c 50、100和200 mg/kg分别使肾脏中PMB的蓄积量降低了18.5%、39.1%(p < 0.01)和36.8%(p < 0.01),并分别使24小时N-乙酰-β-D-氨基葡萄糖苷酶排泄量降低了22.5%(p < 0.05)、40.4%(p < 0.01)和40.4%(p < 0.01)。100 mg/kg和200 mg/kg的cyto c显著减轻了PMB所致的肾脏病理损伤。然而,各组间SCr、BUN和血β-MG水平无显著差异。这些结果表明,cyto c可能在大鼠模型中抑制PMB的肾蓄积及肾毒性,进一步证明了巨膜蛋白在PMB蓄积中的作用。